Testicular dysgenesis syndrome: possible role of endocrine disrupters

Area of Science:

• Reproductive biology
• Developmental toxicology
• Endocrinology

Background:

• Testicular dysgenesis syndrome (TDS) is a hypothesis linking cryptorchidism, hypospadias, impaired spermatogenesis, and testicular cancer.
• These conditions are proposed to stem from disturbed prenatal testicular development.
• Epidemiological, clinical, and molecular studies suggest an interrelation between TDS components.

Purpose of the Study:

• To explore the hypothesis that cryptorchidism, hypospadias, impaired spermatogenesis, and testicular cancer are manifestations of disturbed prenatal testicular development.
• To investigate the role of genetic and environmental factors, including endocrine disruptors, in the etiology of TDS.
• To highlight the clinical relevance and management strategies for TDS.

Main Methods:

• Review of epidemiological, clinical, and molecular studies on TDS.
• Consideration of evidence from human studies on endocrine disruptors and TDS components.
• Emphasis on the utility of animal TDS models for investigating pathogenesis due to ethical limitations in human studies.

Main Results:

• Few human studies have established associations between endocrine disruptors (e.g., phthalates) and TDS components.
• Establishing a causal relationship between prenatal exposure and TDS in humans is ethically challenging.
• Animal TDS models are crucial for understanding TDS pathogenesis.

Conclusions:

• TDS encompasses a spectrum of conditions related to prenatal testicular development disturbances.
• Reduced sperm concentration is a common manifestation, while testicular cancer represents a severe form.
• Clinicians should recognize the interconnectedness of TDS features and consider early testicular cancer detection in infertile men with poor semen quality.